BACKGROUND: Congenital hearing loss is one of the most common sensory disorders, with 50-70% of cases attributable to genetic causes. Although recent advances in the identification of deafness genes have resulted in more accurate molecular diagnosis, leading to the better determination of suitable clinical interventions, difficulties remain with regard to clinical applications due to the extreme genetic heterogeneity of deafness. AIM: Toward more effective genetic testing, we adopted Massively Parallel DNA Sequencing (MPS) of target genes using an Ion PGM™ system and an Ion AmpliSeq™ panel to diagnose common mutations responsible for deafness and discover rare causative gene mutations. Before its clinical application, we investigated the accuracy of MPS-based genetic testing. RESULTS: We compared the results of Invader assay-based genetic screening, the accuracy of which has already been verified in previous studies, with those of MPS-based genetic testing for a large population of Japanese deafness patients and revealed that over 99.98% of the results were the same for each genetic testing system. CONCLUSION: The Ion Personal Genome Machine system had sufficient uniformity and accuracy for application to the clinical diagnosis of common causative mutations and efficiently identified rare causative mutations and/or mutation candidates.
BACKGROUND:Congenital hearing loss is one of the most common sensory disorders, with 50-70% of cases attributable to genetic causes. Although recent advances in the identification of deafness genes have resulted in more accurate molecular diagnosis, leading to the better determination of suitable clinical interventions, difficulties remain with regard to clinical applications due to the extreme genetic heterogeneity of deafness. AIM: Toward more effective genetic testing, we adopted Massively Parallel DNA Sequencing (MPS) of target genes using an Ion PGM™ system and an Ion AmpliSeq™ panel to diagnose common mutations responsible for deafness and discover rare causative gene mutations. Before its clinical application, we investigated the accuracy of MPS-based genetic testing. RESULTS: We compared the results of Invader assay-based genetic screening, the accuracy of which has already been verified in previous studies, with those of MPS-based genetic testing for a large population of Japanese deafnesspatients and revealed that over 99.98% of the results were the same for each genetic testing system. CONCLUSION: The Ion Personal Genome Machine system had sufficient uniformity and accuracy for application to the clinical diagnosis of common causative mutations and efficiently identified rare causative mutations and/or mutation candidates.
Authors: A Eliot Shearer; Adam P DeLuca; Michael S Hildebrand; Kyle R Taylor; José Gurrola; Steve Scherer; Todd E Scheetz; Richard J H Smith Journal: Proc Natl Acad Sci U S A Date: 2010-11-15 Impact factor: 11.205
Authors: Bangzhou Zhang; C Ryan Penton; Chao Xue; Qiong Wang; Tianling Zheng; James M Tiedje Journal: Appl Environ Microbiol Date: 2015-04-24 Impact factor: 4.792
Authors: Allen S Ho; Angelica Ochoa; Gowtham Jayakumaran; Ahmet Zehir; Cristina Valero Mayor; Justin Tepe; Vladimir Makarov; Martin G Dalin; Jie He; Mark Bailey; Meagan Montesion; Jeffrey S Ross; Vincent A Miller; Lindsay Chan; Ian Ganly; Snjezana Dogan; Nora Katabi; Petros Tsipouras; Patrick Ha; Nishant Agrawal; David B Solit; P Andrew Futreal; Adel K El Naggar; Jorge S Reis-Filho; Britta Weigelt; Alan L Ho; Nikolaus Schultz; Timothy A Chan; Luc Gt Morris Journal: J Clin Invest Date: 2019-10-01 Impact factor: 14.808
Authors: Jamie M Ellingford; Christopher Campbell; Stephanie Barton; Sanjeev Bhaskar; Saurabh Gupta; Rachel L Taylor; Panagiotis I Sergouniotis; Bradley Horn; Janine A Lamb; Michel Michaelides; Andrew R Webster; William G Newman; Binay Panda; Simon C Ramsden; Graeme Cm Black Journal: Eur J Hum Genet Date: 2017-04-05 Impact factor: 4.246
Authors: Charlotte L Alston; Caoimhe Howard; Monika Oláhová; Steven A Hardy; Langping He; Philip G Murray; Siobhan O'Sullivan; Gary Doherty; Julian P H Shield; Iain P Hargreaves; Ardeshir A Monavari; Ina Knerr; Peter McCarthy; Andrew A M Morris; David R Thorburn; Holger Prokisch; Peter E Clayton; Robert McFarland; Joanne Hughes; Ellen Crushell; Robert W Taylor Journal: J Med Genet Date: 2016-04-18 Impact factor: 6.318
Authors: Bourlaye Fofana; Kaushik Ghose; Ashok Somalraju; Jason McCallum; David Main; Michael K Deyholos; Gordon G Rowland; Sylvie Cloutier Journal: Front Plant Sci Date: 2017-09-21 Impact factor: 5.753